Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
retinoic acid nuclear receptor alpha variant 1 | 16 | 0 | 0 | 16 |
retinoid X nuclear receptor alpha | 16 | 0 | 0 | 16 |
estrogen-related nuclear receptor alpha | 21 | 0 | 0 | 21 |
pregnane X nuclear receptor | 15 | 0 | 0 | 15 |
Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
Luciferase | 12 | 0 | 0 | 12 |
thioredoxin reductase | 7 | 0 | 0 | 7 |
ATAD5 protein, partial | 9 | 0 | 0 | 9 |
NPC intracellular cholesterol transporter 1 precursor | 4 | 0 | 0 | 4 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
ras-related protein Rab-9A | 4 | 0 | 0 | 4 |
DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
nuclear receptor ROR-gamma isoform 1 | 9 | 0 | 0 | 9 |
G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Quinolone resistance protein NorA | 0 | 0 | 0 | 1 |
G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
NAD(P)H dehydrogenase [quinone] 1 | 0 | 0 | 0 | 1 |
G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 4 | 0 | 4 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
glp-1 receptor, partial | 5 | 0 | 0 | 5 |
hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
RAR-related orphan receptor gamma | 15 | 0 | 0 | 15 |
Fumarate hydratase | 7 | 0 | 0 | 7 |
TDP1 protein | 18 | 0 | 0 | 18 |
GLI family zinc finger 3 | 13 | 0 | 0 | 13 |
AR protein | 17 | 0 | 0 | 17 |
caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 13 | 0 | 0 | 13 |
progesterone receptor | 11 | 0 | 0 | 11 |
glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
estrogen nuclear receptor alpha | 19 | 0 | 0 | 19 |
polyprotein | 7 | 0 | 0 | 7 |
67.9K protein | 6 | 0 | 0 | 6 |
peroxisome proliferator activated receptor gamma | 10 | 0 | 0 | 10 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 12 | 0 | 0 | 12 |
caspase-3 | 3 | 0 | 0 | 3 |
IDH1 | 6 | 0 | 0 | 6 |
euchromatic histone-lysine N-methyltransferase 2 | 18 | 0 | 0 | 18 |
aryl hydrocarbon receptor | 10 | 0 | 0 | 10 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 9 | 0 | 0 | 9 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
Histone H2A.x | 14 | 0 | 0 | 14 |
cellular tumor antigen p53 isoform a | 7 | 0 | 0 | 7 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 12 | 0 | 0 | 12 |
chromobox protein homolog 1 | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
thyroid hormone receptor beta isoform 2 | 12 | 0 | 0 | 12 |
histone deacetylase 9 isoform 3 | 6 | 0 | 0 | 6 |
heat shock protein beta-1 | 6 | 0 | 0 | 6 |
mitogen-activated protein kinase 1 | 11 | 0 | 0 | 11 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
geminin | 13 | 0 | 0 | 13 |
Vif | 0 | 1 | 0 | 2 |
peripheral myelin protein 22 | 7 | 0 | 0 | 7 |
survival motor neuron protein isoform d | 9 | 0 | 0 | 9 |
muscleblind-like protein 1 isoform 1 | 7 | 0 | 0 | 7 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 1 | 0 | 2 |
lamin isoform A-delta10 | 14 | 0 | 0 | 14 |
neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 13 | 0 | 13 |
Multidrug resistance-associated protein 4 | 0 | 13 | 0 | 13 |
Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
Bile salt export pump | 0 | 17 | 0 | 17 |
Interferon beta | 11 | 0 | 0 | 11 |
Cellular tumor antigen p53 | 14 | 0 | 0 | 14 |
Integrin beta-3 | 6 | 1 | 0 | 7 |
Integrin alpha-IIb | 6 | 1 | 0 | 7 |
Methionine aminopeptidase | 0 | 2 | 0 | 2 |
Glutamate receptor 2 | 9 | 0 | 0 | 9 |
Fatty-acid amide hydrolase 1 | 1 | 2 | 0 | 3 |
Inositol monophosphatase 1 | 7 | 0 | 0 | 7 |
Canalicular multispecific organic anion transporter 1 | 0 | 11 | 0 | 11 |
ATPase family AAA domain-containing protein 5 | 8 | 0 | 0 | 8 |
Ataxin-2 | 9 | 0 | 0 | 9 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 10 | 0 | 0 | 10 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 10 | 0 | 0 | 10 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 10 | 0 | 0 | 10 |
Chain B, HADH2 protein | 10 | 0 | 0 | 10 |
Chain A, 2-oxoglutarate Oxygenase | 13 | 0 | 0 | 13 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 3 | 0 | 0 | 3 |
GLS protein | 4 | 0 | 0 | 4 |
aldehyde dehydrogenase 1 family, member A1 | 17 | 0 | 0 | 17 |
thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
hypothetical protein, conserved | 6 | 0 | 0 | 6 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 12 | 0 | 0 | 12 |
EWS/FLI fusion protein | 8 | 0 | 0 | 8 |
cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
peroxisome proliferator-activated receptor delta | 10 | 0 | 0 | 10 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
DNA polymerase kappa isoform 1 | 9 | 0 | 0 | 9 |
muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 7 | 0 | 0 | 7 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 4 | 0 | 4 |
Carbonic anhydrase 1 | 0 | 6 | 0 | 7 |
Carbonic anhydrase 2 | 0 | 6 | 0 | 7 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 3 | 0 | 10 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 7 | 0 | 0 | 7 |
Chain A, Cruzipain | 7 | 0 | 0 | 7 |
phosphopantetheinyl transferase | 11 | 0 | 0 | 11 |
USP1 protein, partial | 10 | 0 | 0 | 10 |
Microtubule-associated protein tau | 9 | 0 | 0 | 10 |
vitamin D3 receptor isoform VDRA | 11 | 0 | 0 | 11 |
caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
Caspase-7 | 3 | 0 | 0 | 3 |
Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 6 |
Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 6 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
acetylcholinesterase | 6 | 0 | 0 | 6 |
leucine aminopeptidase | 0 | 1 | 0 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
M17 leucyl aminopeptidase | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7 | 0 | 0 | 7 |
estrogen receptor 2 (ER beta) | 8 | 0 | 0 | 8 |
nonstructural protein 1 | 4 | 0 | 0 | 4 |
G | 9 | 0 | 0 | 9 |
M18 aspartyl aminopeptidase | 0 | 1 | 0 | 1 |
M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
histone acetyltransferase KAT2A isoform 1 | 9 | 0 | 0 | 9 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 5 | 0 | 0 | 5 |
Histone deacetylase 3 | 0 | 1 | 1 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 10 | 0 | 0 | 10 |
Histone deacetylase 1 | 0 | 1 | 1 | 2 |
Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
Histone deacetylase 2 | 0 | 1 | 1 | 2 |
Polyamine deacetylase HDAC10 | 0 | 1 | 1 | 2 |
5-lipoxygenase | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 1 | 1 | 2 |
Histone deacetylase 6 | 0 | 1 | 1 | 2 |
cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
M17 leucyl aminopeptidase | 0 | 1 | 0 | 1 |
M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
cytochrome P450 2C9 precursor | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit pi | 7 | 2 | 0 | 9 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 2 | 0 | 2 |
DNA gyrase subunit A | 0 | 2 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 3 | 0 | 3 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 3 | 0 | 5 |
DNA gyrase subunit B | 0 | 3 | 0 | 5 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 2 | 0 | 3 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 4 |
Cytochrome P450 2C9 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit delta | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 2 | 0 | 9 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 2 | 0 | 9 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Multidrug resistance protein MdtK | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 2 | 0 | 9 |
DNA gyrase subunit B | 0 | 2 | 0 | 2 |
DNA gyrase subunit A | 0 | 2 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 3 |
DNA topoisomerase 4 subunit A | 0 | 2 | 0 | 2 |
DNA topoisomerase 4 subunit B | 0 | 2 | 0 | 2 |
Integrase | 0 | 1 | 0 | 1 |
GABA theta subunit | 7 | 2 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit epsilon | 7 | 2 | 0 | 9 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
mu opioid receptor, partial | 0 | 0 | 1 | 1 |
15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
SMAD family member 2 | 8 | 0 | 0 | 8 |
SMAD family member 3 | 8 | 0 | 0 | 8 |
thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
Smad3 | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
bromodomain adjacent to zinc finger domain 2B | 7 | 0 | 0 | 7 |
LAP4 | 0 | 0 | 2 | 2 |
MEP2 | 0 | 0 | 2 | 2 |
activating transcription factor 6 | 9 | 0 | 0 | 9 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
delta-type opioid receptor | 0 | 1 | 1 | 2 |
kappa-type opioid receptor isoform 1 | 0 | 1 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
huntingtin isoform 2 | 8 | 0 | 0 | 8 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 6 | 0 | 0 | 6 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 7 | 0 | 0 | 7 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 14 | 0 | 0 | 14 |
cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
Spike glycoprotein | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 6 | 1 | 7 |
Catechol O-methyltransferase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 2 | 1 | 3 |
Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
Alpha-synuclein | 2 | 0 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 6 | 1 | 7 |
Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 5 | 0 | 0 | 5 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
Beta-galactosidase | 0 | 0 | 1 | 1 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 2 |
metallo beta-lactamase | 0 | 1 | 0 | 1 |
metallo-beta-lactamase IMP-1 | 0 | 1 | 0 | 1 |
LANA | 0 | 0 | 0 | 1 |
glutathione S-transferase, partial | 0 | 0 | 1 | 1 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
insulin-degrading enzyme isoform 1 | 0 | 0 | 1 | 1 |
serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
eyes absent homolog 2 isoform a | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
Glycoprotein hormones alpha chain | 2 | 0 | 0 | 2 |
B1 bradykinin receptor | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
ORF73 | 0 | 0 | 1 | 2 |
BZLF2 | 0 | 1 | 0 | 1 |
Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 0 | 1 | 3 |
Albumin | 0 | 1 | 2 | 3 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
Thrombopoietin | 1 | 0 | 0 | 1 |
signal transducer and activator of transcription 6, interleukin-4 induced | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 2 |
NS5 | 0 | 0 | 1 | 1 |
PPM1D protein | 5 | 0 | 0 | 5 |
Parkin | 1 | 0 | 0 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Glucose transporter | 0 | 1 | 0 | 1 |
Serine hydrolase RBBP9 | 0 | 1 | 0 | 1 |
Hexose transporter 1 | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 1 | 1 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 1 | 3 |
Alpha-2A adrenergic receptor | 0 | 5 | 0 | 5 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
Spike glycoprotein | 7 | 0 | 1 | 8 |
Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 2 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 2 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 7 | 0 | 0 | 7 |
Genome polyprotein | 0 | 1 | 1 | 2 |
chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 2 | 2 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
large T antigen | 0 | 3 | 0 | 3 |
pregnane X receptor | 3 | 0 | 0 | 3 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | 1 | 0 | 0 | 1 |
alpha synuclein, partial | 1 | 0 | 0 | 1 |
luciferase | 3 | 0 | 0 | 3 |
Caspase-7 | 2 | 0 | 0 | 2 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
caspase-3 | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 4 | 0 | 4 |
60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 4 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, kainate 1 | 1 | 0 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 2 | 1 | 0 | 0 | 1 |
Glutamate receptor ionotropic, kainate 3 | 1 | 0 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, kainate 4 | 1 | 0 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Leukotriene B4 receptor 1 | 1 | 0 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, kainate 5 | 1 | 0 | 0 | 1 |
10 kDa chaperonin | 0 | 3 | 0 | 3 |
Leukotriene B4 receptor 2 | 1 | 0 | 0 | 1 |
Chain E, Fibrin beta chain | 0 | 2 | 0 | 2 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
MPI protein | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
pyruvate kinase | 2 | 0 | 0 | 2 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
CDK5 | 0 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 3 | 0 | 0 | 3 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
Tat | 0 | 1 | 0 | 1 |
alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
Pyruvate kinase PKM | 0 | 2 | 0 | 2 |
Endothelin receptor type B | 2 | 0 | 0 | 2 |
Endothelin-1 receptor | 2 | 0 | 0 | 2 |
phosphoglycerate kinase | 2 | 0 | 0 | 2 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
citrate synthase 2, partial | 0 | 0 | 1 | 1 |
PAX8 | 0 | 0 | 0 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 2 | 0 | 2 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 2 | 0 | 2 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Calmodulin-domain protein kinase 1 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 1 | 2 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase TEM | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 1 | 2 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 1 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 3 |
Tumor necrosis factor | 0 | 1 | 1 | 2 |
Neuraminidase | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 1 | 0 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
Cystine/glutamate transporter | 0 | 2 | 0 | 2 |
Hydroxyacid oxidase 1 | 0 | 1 | 0 | 1 |
T cell receptor, partial | 1 | 0 | 0 | 1 |
luteinizing hormone receptor | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
TSHR protein | 1 | 0 | 0 | 1 |
Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform a | 2 | 0 | 0 | 2 |
caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
Albumin | 0 | 0 | 0 | 1 |
Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 0 | 1 | 1 |
Cruzipain | 0 | 1 | 0 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Signal transducer and activator of transcription 3 | 0 | 1 | 0 | 1 |
Pyruvate-flavodoxin oxidoreductase | 0 | 1 | 0 | 1 |
Anoctamin-1 | 0 | 1 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
Delta-type opioid receptor | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 3 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Class A sortase SrtA | 0 | 1 | 0 | 1 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 0 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
Chain A, Glutathione S-transferase | 0 | 1 | 0 | 1 |
Interstitial collagenase | 0 | 1 | 0 | 1 |
Fibroblast growth factor 1 | 0 | 0 | 1 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 1 | 0 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |